Optimierung der Antiinfektivatherapie mittels therapeutischen Drug-Monitorings-Reference-Cited by-同舟云学术

Optimierung der Antiinfektivatherapie mittels therapeutischen Drug-Monitorings

Published:2014-11 Issue:6 Volume:9 Page:457-464
ISSN:1862-040X
Container-title:Der Nephrologe
language:de
Short-container-title:Nephrologe

Author:

Bode-Böger S.M.

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s11560-014-0951-4.pdf

Reference24 articles.

1. Bhavnani SM, Rubino CM, Ambrose PG, Drusano GL (2010) Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis. Clin Infect Dis 50:1568–1574

2. Binder L, Schwörer H, Hoppe S et al (2013) Pharmacokinetics of meropenem in critically ill patients with severe infections. Ther Drug Monit 35:63–70

3. Bode-Böger SM, Böger RH, Frölich JC (1993) Therapeutisches Drug-Monitoring in der Praxis – Indikationen und Interpretationen. Z Ärztl Fortbild 87:201–210

4. Bode-Böger SM, Schopp B, Tröger U et al (2013) Intravenous colistin in a patient with serious burns and borderline syndrome: the benefits of therpeutic drug monitoring. Int J Antimicrob Agents 42:357–360

5. Burkhardt O, Hafer C, Langhoff A et al (2009) Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis. Nephrol Dial Transplant 24:267–271

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustainable implementation of antibiotic stewardship on a surgical intensive care unit evaluated over a 10-year period;Infection;2019-11-13